Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase 1 trial (Annals of Neurology (2007) (399-495))

Amit Bar-Or; Peter A.J. Calabresi; Douglas Arnold; Clyde Markowitz; Stuart Shafer; Lloyd H. Kasper; Emmanuelle Waubant; Suzanne Gazda; Robert J. Fox; Michael Panzara; Neena Sarkar; Sunil Agarwal; Craig H. Smith

doi:10.1002/ana.21441

Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase 1 trial (Annals of Neurology (2007) (399-495))

Amit Bar-Or, Peter A.J. Calabresi, Douglas Arnold, Clyde Markowitz, Stuart Shafer, Lloyd H. Kasper, Emmanuelle Waubant, Suzanne Gazda, Robert J. Fox, Michael Panzara, Neena Sarkar, Sunil Agarwal, Craig H. Smith

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Number of pages	1
Journal	Annals of neurology
Volume	63
Issue number	6
DOIs	https://doi.org/10.1002/ana.21441
State	Published - Jun 1 2008
Externally published	Yes

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1002/ana.21441

Cite this

Bar-Or, A., Calabresi, P. A. J., Arnold, D., Markowitz, C., Shafer, S., Kasper, L. H., Waubant, E., Gazda, S., Fox, R. J., Panzara, M., Sarkar, N., Agarwal, S., & Smith, C. H. (2008). Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase 1 trial (Annals of Neurology (2007) (399-495)). Annals of neurology, 63(6). https://doi.org/10.1002/ana.21441

@article{70dbc201a6574531a70455fee839739e,

title = "Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase 1 trial (Annals of Neurology (2007) (399-495))",

author = "Amit Bar-Or and Calabresi, {Peter A.J.} and Douglas Arnold and Clyde Markowitz and Stuart Shafer and Kasper, {Lloyd H.} and Emmanuelle Waubant and Suzanne Gazda and Fox, {Robert J.} and Michael Panzara and Neena Sarkar and Sunil Agarwal and Smith, {Craig H.}",

year = "2008",

month = jun,

day = "1",

doi = "10.1002/ana.21441",

language = "English (US)",

volume = "63",

journal = "Annals of Neurology",

issn = "0364-5134",

publisher = "John Wiley and Sons Inc.",

number = "6",

}

TY - JOUR

T1 - Rituximab in relapsing-remitting multiple sclerosis

T2 - A 72-week, open-label, phase 1 trial (Annals of Neurology (2007) (399-495))

AU - Bar-Or, Amit

AU - Calabresi, Peter A.J.

AU - Arnold, Douglas

AU - Markowitz, Clyde

AU - Shafer, Stuart

AU - Kasper, Lloyd H.

AU - Waubant, Emmanuelle

AU - Gazda, Suzanne

AU - Fox, Robert J.

AU - Panzara, Michael

AU - Sarkar, Neena

AU - Agarwal, Sunil

AU - Smith, Craig H.

PY - 2008/6/1

Y1 - 2008/6/1

UR - http://www.scopus.com/inward/record.url?scp=46749140939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46749140939&partnerID=8YFLogxK

U2 - 10.1002/ana.21441

DO - 10.1002/ana.21441

M3 - Comment/debate

AN - SCOPUS:46749140939

SN - 0364-5134

VL - 63

JO - Annals of Neurology

JF - Annals of Neurology

IS - 6

ER -

Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase 1 trial (Annals of Neurology (2007) (399-495))

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this